首页> 外文期刊>Laryngo- rhino- otologie >Coagulation factors as potential tumour markers in patients with head and neck carcinomas? [Gerinnungsfaktoren als potenzielle tumormarker bei patienten mit kopf-hals-karzinomen?]
【24h】

Coagulation factors as potential tumour markers in patients with head and neck carcinomas? [Gerinnungsfaktoren als potenzielle tumormarker bei patienten mit kopf-hals-karzinomen?]

机译:凝血因子可作为头颈癌患者潜在的肿瘤标志物?凝血因子作为头颈癌患者潜在的肿瘤标志物?

获取原文
获取原文并翻译 | 示例
           

摘要

Coagulation Factors as Potential Tumour Markers in Patients with Head and Neck Carcinomas? Objective: Carcinomas can have influence on the coagulation system by different factors. Locally pathological changes of metabolism, neo-vascularisation, oxygenation and tissue pressure as well as locally and systemically activities of the tumor cells, are part of it. The coagulation situation in patients with head and neck carcinomata is characterized only insufficiently till now. Material and methods: In a prospective pilot study 20 male patients with squamous-cell carcinomas of the head and neck area were subjected to a detailed coagulation diagnostics pr? and post therapeutically and, age and sex corrected, compared with a control group (n=37). Results: For the routine parameters PTT, Quick, TZ and INR no differences between the groups could be recognized. For the tumour patients a statistically significant increase arose for the acute phase proteins like factor I (fibrinogen), factor VIII, factor IX, von- Willebrand antigen and activity before therapy. Increased values were found also for plasmin, factor II, factor V and the thrombin-antithrombin-III-complex (TAT) whereas the values for antithrombin-III were degraded significantly. In the tumour patients the pr?therapeutical increased values for the activation marker TAT brought themselves back to normal after the tumour ablative therapy. Conclusions: TAT could be suitable as a potential tumourmarker but also for relapse tumours. To evidence this, a study of longer duration and with a larger number of patients is necessary.
机译:凝血因子作为头颈部癌患者潜在的肿瘤标志物?目的:癌可以通过不同因素影响凝血系统。代谢的局部病理变化,新血管形成,氧合和组织压力以及肿瘤细胞的局部和全身活性是其中的一部分。到目前为止,头颈癌患者的凝血情况尚不充分。材料和方法:在一项前瞻性先导研究中,对20名男性头颈部鳞状细胞癌患者进行了详细的凝血诊断。与对照组相比(n = 37)。结果:对于常规参数PTT,Quick,TZ和INR,两组之间没有区别。对于肿瘤患者,急性期蛋白如因子I(纤维蛋白原),因子VIII,因子IX,von-Willebrand抗原和治疗前的活性在统计学上显着增加。还发现纤溶酶,因子II,因子V和凝血酶-抗凝血酶-III-复合物(TAT)的值增加,而抗凝血酶-III的值显着降低。在肿瘤患者中,激活标记物TAT的实际治疗价值在肿瘤消融治疗后恢复正常。结论:TAT既可以作为潜在的肿瘤标志物,也可以用于复发性肿瘤。为了证明这一点,有必要对更长的持续时间和更多的患者进行研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号